FDA Approves DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Amneal Pharmaceuticals of New York LLC

Amneal Pharmaceuticals received FDA approval Wednesday for a supplemental ANDA to manufacture generic dexmethylphenidate (Ritalin La), an oral treatment for ADHD. The New York-based company faces anticipated biosimilars from Teva and Mylan in the coming years, potentially pressuring generic pricing for the brand product.